L F Fries

Summary

Publications

  1. pmc Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults
    L F Fries
    Intellivax, Inc, Baltimore, Maryland 21227, USA
    Infect Immun 69:4545-53. 2001

Collaborators

Detail Information

Publications1

  1. pmc Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults
    L F Fries
    Intellivax, Inc, Baltimore, Maryland 21227, USA
    Infect Immun 69:4545-53. 2001
    ..flexneri 2a LPS vaccine is similar to those reported for live vaccine candidates associated with protective efficacy in human challenge models, and further evaluation of this product is warranted...